Comparing the Incidence of Preeclampsia Between Pregnant Women Receiving Tdap Vaccinations at Week 28 or at Week 36

PHASE4UnknownINTERVENTIONAL
Enrollment

1,600

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

October 1, 2023

Study Completion Date

December 31, 2024

Conditions
Pre-EclampsiaDiphtheria, Tetanus and Pertussis Vaccine Reaction
Interventions
DRUG

Tdap Vaccine Administration

Tdap vaccinations are routinely given during pregnancy between weeks 27 and 36 per guidelines of American College Obstetrics and Gynecology (ACOG) -- but this study uniquely is trying to establish that the earlier Tdap vaccinations reduce preeclampsia by more than 50%

Trial Locations (1)

83404

Institute of Arthritis Research, Idaho Falls

All Listed Sponsors
collaborator

Louisiana State University Health Sciences Center in New Orleans

OTHER

collaborator

Brigham Young University

OTHER

lead

Institute of Arthritis Research

OTHER